Compare TS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TS | DGX |
|---|---|---|
| Founded | 2001 | 1967 |
| Country | Luxembourg | United States |
| Employees | 24875 | N/A |
| Industry | Steel/Iron Ore | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.3B | 23.2B |
| IPO Year | N/A | 1996 |
| Metric | TS | DGX |
|---|---|---|
| Price | $56.42 | $233.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $58.80 | ★ $214.38 |
| AVG Volume (30 Days) | 1.0M | ★ 1.0M |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | ★ 2.80% | 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | N/A | ★ 5.08 |
| Revenue | N/A | ★ $11,035,000,000.00 |
| Revenue This Year | $1.53 | $7.53 |
| Revenue Next Year | $3.59 | $3.77 |
| P/E Ratio | ★ $12.59 | $46.30 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $33.71 | $167.96 |
| 52 Week High | $64.60 | $240.13 |
| Indicator | TS | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 44.57 | 75.45 |
| Support Level | $53.44 | $190.42 |
| Resistance Level | $60.01 | N/A |
| Average True Range (ATR) | 1.14 | 6.80 |
| MACD | 0.16 | 2.64 |
| Stochastic Oscillator | 18.50 | 87.45 |
Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.